The elastic properties of the Cryptococcus neoformans capsule.
Microbial capsules are important for virulence, but their architecture and physical properties are poorly understood. The human pathogenic fungus Cryptococcus neoformans has a large polysaccharide capsule that is necessary for virulence and is the target of protective antibody responses. To study the C. neoformans capsule we developed what we believe is a new approach whereby we probed the capsular elastic properties by applying forces using polystyrene beads manipulated with optical tweezers. This method allowed us to determine the Young's modulus for the capsule in various conditions that affect capsule growth. The results indicate that the Young's modulus of the capsule decreases with its size and increases with the Ca(2+) concentration in solution. Also, capsular polysaccharide manifests an unexpected affinity for polystyrene beads, a property that may function in attachment to host cells and environmental structures. Bead probing with optical tweezers provides a new, nondestructive method that may have wide applicability for studying the effects of growth conditions, immune components, and drugs on capsular properties.
Frases
Susana
S
Department of Microbiology and Immunology, Albert Einstein College of Medicine, The Bronx, New York, USA. scarvaja@aecom.yu.edu
Pontes
Bruno
B
Nimrichter
Leonardo
L
Rodrigues
Marcio L
ML
Viana
Nathan B
NB
Casadevall
Arturo
A
D003455:Cryptococcus neoformans / Q000737:chemistry* / Q000502:physiology*; D055119:Elastic Modulus / Q000502:physiology; D052898:Optical Tweezers; D011134:Polysaccharides / Q000737:chemistry* / Q000502:physiology*; D013314:Stress, Mechanical
D011134:Polysaccharides
Phys Rev Lett. 2000 Feb 14;84(7):1627-30
11017584
J Bacteriol. 2008 Jun;190(12):4225-32
18408030
Trends Microbiol. 2000 Dec;8(12):547-53
11115750
Biophys J. 2007 Mar 15;92(6):1825-35
17158578
Eukaryot Cell. 2008 Feb;7(2):319-27
18156290
Biol Proced Online. 2004;6:10-15
15103395
J Biomech Eng. 2002 Aug;124(4):408-21
12188207
J Clin Invest. 2003 Oct;112(7):1080-94
14523045
Am J Pathol. 2005 Feb;166(2):421-32
15681826
Trends Microbiol. 2006 Nov;14(11):497-505
16996739
J Immunol. 1982 Oct;129(4):1675-80
7050244
Mol Microbiol. 2006 Jan;59(1):67-83
16359319
Clin Diagn Lab Immunol. 1998 Mar;5(2):146-59
9521136
Rev Infect Dis. 1988 Jul-Aug;10 Suppl 2:S436-9
3055212
Infect Immun. 1998 Oct;66(10):5027-30
9746613
Cell Microbiol. 2006 Dec;8(12):1862-76
16824038
Vaccine. 2005 Jun 10;23(30):3961-72
15917118
Infect Immun. 2001 May;69(5):3398-409
11292763
Antimicrob Agents Chemother. 1998 Jun;42(6):1437-46
9624491
Mol Microbiol. 2004 Apr;52(1):13-24
15049807
Med Mycol. 1999 Aug;37(4):235-43
10421858
J Biol Chem. 2006 Jan 27;281(4):1868-75
16278213
J Bacteriol. 2005 Jun;187(11):3864-8
15901713
Mol Immunol. 2003 Oct;40(6):351-61
14522016
Cell Microbiol. 2008 Oct;10(10):2043-57
18554313
Eukaryot Cell. 2008 Mar;7(3):546-9
18156288
Eukaryot Cell. 2007 Aug;6(8):1400-10
17573547
Clin Vaccine Immunol. 2007 Jan;14(1):94-8
17093102
Rev Sci Instrum. 2004 Sep;75(9):2787-809
16878180
Microbes Infect. 2004 Dec;6(15):1351-5
15596119
Infect Immun. 2003 Nov;71(11):6155-64
14573631
Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1228-33
19164571
Phys Rev E Stat Nonlin Soft Matter Phys. 2007 Feb;75(2 Pt 1):021914
17358374
Mol Microbiol. 2003 Nov;50(4):1401-9
14622425